FREE SHIPPING ON ORDERS OVER $150

dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD fig2.gif

$25.91

Quantity
- +
Description

Neuroprotection of Exendin-4 by enhanced autophagy in a Parkinsonian Rat Model of alpha-Synucleinopathy

dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD fig2.gif

It is marketed there under the brand name Lirasen

dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD fig2.gif

The authors also suggest a second potential pathway independent of GLP-1 for some of the cardiovascular effects

dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD fig2.gif

Non-HDL cholesterol and apolipoprotein B may also show modest improvements, which better reflect atherogenic lipoprotein burden

dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD fig2.gif

Ahmed IA

dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD fig2.gif

PMID: 60 SontamTChenHRamanJChenAChoSWTarboxM

dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD fig2.gif

You may also like

recommand products